Medical Properties Trust (MPT) Stock Overview
A self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 4/6 |
MPT Community Fair Values
Create NarrativeSee what 175 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Medical Properties Trust, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$4.12 |
| 52 Week High | US$6.47 |
| 52 Week Low | US$3.96 |
| Beta | 1.46 |
| 1 Month Change | -14.35% |
| 3 Month Change | -18.90% |
| 1 Year Change | -4.41% |
| 3 Year Change | -41.23% |
| 5 Year Change | -79.48% |
| Change since IPO | -62.55% |
Recent News & Updates
Seeking Alpha • Aug 19
Unlocking Deep Asset Value In Medical Properties Trust
Summary Medical Properties Trust's $2.4 billion financing package pushes major debt maturities out to 2032—eliminating immediate refinancing risk at the expense of higher interest costs. A clear look at the $0.057 per share quarterly FFO headwind from the new 9.25% Senior Notes and how upcoming rent ramp-ups aim to cushion the impact. The $1.1 billion asset sale pipeline is achieving prices substantially higher than original cost bases. MPT's stock continues to trade at a steep discount to its depreciated book value ($7.31/share) and its raw real estate cost basis ($10.27/share). Read the full article on Seeking Alpha
Narrative Update • Aug 12
MPT: Balance Sheet Actions And Essential Assets Will Support Future Re Rating
Medical Properties Trust enters this Narrative Update with a reduced analyst fair value estimate of $7.00 from $8.00, as analysts factor in lower revenue growth expectations, a slimmer profit margin profile, a slightly higher discount rate, and a higher assumed future P/E multiple. Analyst Commentary on Medical Properties Trust Recent Street research does not directly address Medical Properties Trust, but it does highlight how bullish analysts are thinking about valuation, execution, and growth for income oriented and asset heavy companies more broadly.Recent updates
Seeking Alpha • Aug 19
Unlocking Deep Asset Value In Medical Properties Trust
Summary Medical Properties Trust's $2.4 billion financing package pushes major debt maturities out to 2032—eliminating immediate refinancing risk at the expense of higher interest costs. A clear look at the $0.057 per share quarterly FFO headwind from the new 9.25% Senior Notes and how upcoming rent ramp-ups aim to cushion the impact. The $1.1 billion asset sale pipeline is achieving prices substantially higher than original cost bases. MPT's stock continues to trade at a steep discount to its depreciated book value ($7.31/share) and its raw real estate cost basis ($10.27/share). Read the full article on Seeking AlphaNarrative Update • Aug 12
MPT: Balance Sheet Actions And Essential Assets Will Support Future Re Rating
Medical Properties Trust enters this Narrative Update with a reduced analyst fair value estimate of $7.00 from $8.00, as analysts factor in lower revenue growth expectations, a slimmer profit margin profile, a slightly higher discount rate, and a higher assumed future P/E multiple. Analyst Commentary on Medical Properties Trust Recent Street research does not directly address Medical Properties Trust, but it does highlight how bullish analysts are thinking about valuation, execution, and growth for income oriented and asset heavy companies more broadly.
Narrative Update • Jun 30
MPT: Higher Required Return To Test Funding And Tenant Execution Resilience
Analysts have trimmed their fair value estimate for Medical Properties Trust from $5.00 to $4.50, citing a slightly higher required return of 12.46% and updated assumptions that combine a slower revenue decline with a higher long term profit margin and a lower future P/E multiple. Analyst Commentary Recent valuation work on Medical Properties Trust reflects a more guarded stance from bearish analysts, who have responded to company specific risks by trimming fair value assumptions and requiring a higher return to justify exposure.Narrative Update • Jun 16
MPT: Fair Value Holding As Funding And Tenant Execution Risks Persist
Analysts held their $5.00 fair value estimate for Medical Properties Trust while slightly adjusting underlying assumptions, citing updated views on the discount rate, revenue trends, profit margins, and future P/E to align the price target with recent sector research and valuation frameworks. Analyst Commentary Recent sector research around real estate and income oriented stocks has grown more selective, with investors paying closer attention to balance sheet strength, tenant quality, and payout sustainability.Narrative Update • Jun 02
MPT: Higher Discount Rate And Earnings Timing Will Shape Future Risk Balance
Analysts kept their $5.00 fair value estimate for Medical Properties Trust in place but now apply a slightly higher discount rate and lower revenue growth and profit margin assumptions. This also leads them to use a higher future P/E multiple of about 40.5x versus roughly 24.0x previously.
Narrative Update • May 06
MPT: Future Cash Flows Will Depend On Execution And Balance Sheet Repair
Narrative Update The analyst fair value estimate for Medical Properties Trust has been revised from $5.17 to $5.79. Analysts cite updated expectations for revenue growth, profit margins, and future P/E assumptions as the key drivers of the new price target framework.Narrative Update • Apr 21
MPT: Fair Value Reset Will Test Execution And Funding Resilience
Analysts have raised their fair value estimate for Medical Properties Trust from $4.50 to $5.00, citing updated assumptions for revenue growth, profit margins, and future P/E that they consider more closely aligned with the latest research coverage and sector expectations. Analyst Commentary Recent research on Medical Properties Trust has been mixed, with some firms highlighting potential upside while others focus on execution and valuation risks.Narrative Update • Apr 07
MPT: Reaffirmed Fair Value And Buybacks Will Support Potential Re Rating
Narrative Update: Medical Properties Trust Price Target Shift Analysts have reaffirmed their price target on Medical Properties Trust at $8.00, citing updated assumptions for revenue growth, profit margin, and future P/E that support keeping fair value estimates unchanged. Analyst Commentary Bullish analysts covering Medical Properties Trust have generally framed the reaffirmed US$8.00 price target as consistent with their updated assumptions on revenue, margins, and the future P/E multiple.Narrative Update • Mar 23
MPT: Execution On Rent Collections And Cost Discipline May Drive Re Rating Potential
Narrative Update Analysts have adjusted the price target for Medical Properties Trust to $8.00, reflecting updated views on the discount rate, revenue growth, and profit margin assumptions that were informed by recent bullish initiation commentary on the stock. Analyst Commentary Bullish analysts covering Medical Properties Trust have framed the recent work on the name as supportive of the updated US$8.00 price target, with a particular focus on how revised assumptions for discount rate, revenue growth, and margins could affect valuation.Narrative Update • Mar 08
MPT: Reset Expectations And Execution Risks Will Pressure Cash Flow Resilience
Narrative Update Analysts have updated their price target on Medical Properties Trust to $4.50, citing slightly lower assumed revenue growth, a modestly improved profit margin profile, and a reduced future P/E multiple in their refreshed models. Analyst Commentary Recent research coverage on Medical Properties Trust has been mixed, with at least one firm initiating with a constructive view while other bearish analysts remain focused on execution and valuation risks implied by the updated $4.50 price target.Narrative Update • Feb 22
MPT: Higher Fair Value Assumptions May Support Re Rating Potential
Analysts have lifted their fair value estimate for Medical Properties Trust from $6.00 to $8.00 per share, citing updated assumptions around discount rates, revenue growth, profit margins, and a higher future P/E multiple. Analyst Commentary Bullish analysts covering Medical Properties Trust are leaning into a more constructive view on the shares, which is reflected in the higher fair value estimate.Narrative Update • Feb 08
MPT: Tenant Concentration Will Likely Limit Cash Flow Resilience Ahead
Narrative Update on Medical Properties Trust Analysts lifted their price target on Medical Properties Trust to US$4.50 from US$4.00, reflecting updated assumptions that include a lower discount rate, a higher profit margin, and a reduced future P/E multiple in their models. Analyst Commentary The latest research on Medical Properties Trust includes a cautious stance, even where price targets have been adjusted.Narrative Update • Jan 25
MPW: Future Returns Will Hinge On Execution And Capital Allocation Choices
Analysts lifted their price target on Medical Properties Trust to $4.50 from $4.00, reflecting updated views on the REIT sector after what they describe as a strong third-quarter earnings season for many U.S. REITs. Analyst Commentary Bullish Takeaways Bullish analysts point to what they describe as a strong Q3 earnings season for U.S. REITs, with 69% of companies in the group beating consensus estimates, which they view as a supportive backdrop for reassessing valuations across the sector, including Medical Properties Trust. The higher US$4.50 price target is cited as an indication that, even with a cautious rating, some analysts see room for potential upside from current levels if the company can execute on its plans and the broader REIT group continues to show solid fundamental performance.Narrative Update • Jan 10
MPW: Future Returns Will Depend On Execution And Balance Sheet Repair
Analysts have nudged their price targets on Medical Properties Trust higher, with one firm lifting its target to $4.50 from $4.00 as they factor in a slightly higher fair value estimate, a modestly higher discount rate, and updated assumptions for revenue growth, profit margins, and future P/E multiples. Analyst Commentary Recent Street research on Medical Properties Trust has centered on valuation adjustments rather than rating changes, giving you a clearer sense of how cautious or constructive analysts are on the name at current levels.Narrative Update • Dec 19
MPW: Tenant Concentration And Deleveraging Efforts Will Likely Cap Share Upside
Analysts have nudged their price target on Medical Properties Trust up by 0.50 dollars to 4.50 dollars, citing a modestly lower perceived risk profile and a slightly higher fair value assumption, despite tempered expectations for revenue growth and margins. Analyst Commentary Bearish analysts acknowledge the recent price target increase to 4.50 dollars as a reflection of slightly improved visibility, but they continue to frame Medical Properties Trust as a structurally challenged story within the healthcare REIT space.Narrative Update • Dec 05
MPW: Future Performance Will Reflect Incremental Improvements Amid Ongoing Balance Sheet And Margin Risks
The analyst price target for Medical Properties Trust has been raised by $0.50 to $4.50 as analysts factor in slightly stronger sector level earnings resilience, modestly higher long term revenue growth and a lower discount rate, even as margin expectations edge down. Analyst Commentary Recent commentary on Medical Properties Trust highlights a mixed but more constructive tone around the stock, with the latest target price revision reflecting incremental improvements in fundamentals and sector sentiment rather than a wholesale change in thesis.Narrative Update • Nov 21
MPW: Future Performance Will Reflect Resilient Operations Amid Market Headwinds And Sector Shifts
The analyst price target for Medical Properties Trust was raised by $0.50 to $4.50, as analysts point to a "strong" Q3 earnings season for U.S. REITs despite broader market challenges. Analyst Commentary Recent Street research surrounding Medical Properties Trust highlights mixed perspectives regarding the company's performance and valuation trajectory.Narrative Update • Nov 03
MPW: Share Repurchase Plan And Lease Agreements Will Support Profitability Amid Sector Uncertainty
The analyst price target for Medical Properties Trust has increased modestly from $4.86 to $5.00. Analysts cite improved profit margins and higher fair value estimates, despite weaker projected revenue growth.Narrative Update • Sep 04
International Healthcare Markets Will Benefit From Demographic Trends
Despite a lower Future P/E and improved Net Profit Margin signaling better profitability and valuation, the consensus analyst price target for Medical Properties Trust edged down slightly from $4.93 to $4.86. What's in the News Medical Properties Trust announced a lease agreement with NOR Healthcare Systems Corp.Seeking Alpha • Apr 21
Medical Properties Trust: The Case For A Turnaround (Rating Upgrade)
Summary Portfolio rent coverage metrics are improving and may continue to do so, aided by Medicaid budget cuts which may lead to more funding for acute care hospitals, benefiting MPW's portfolio. MPW is rebuilding via new hospital tenant additions that have good financial standing. This can lead to a recovery in revenues along with improved cash conversion that is already happening. MPW stock's valuations are attractively placed at a deep discount, both vs its comps and vs its own historical trading multiples. Relative technicals vs the S&P 500 suggest a reversal in the works, but the current levels carry some risk for buys. High fixed debt proportions are a headwind risk in a higher-for-longer rates environment, particularly given MPW's high leverage levels. Read the full article on Seeking AlphaSeeking Alpha • Mar 23
Medical Properties Trust: Buying Pressure Builds On Turnaround
Summary Medical Properties Trust is not going bankrupt, with strong liquidity, a healthy asset base, and a well-covered dividend yield. MPW's fiscal 2024 Q4 revenue and FFO beat consensus estimates, trading at a low valuation with significant upside potential. The REIT has reduced debt and diversified its operator base, with Circle Health and Priory Group as major revenue contributors. Read the full article on Seeking Alpha
New Narrative • Mar 22
Liquidity Actions And Asset Sales Will Position Healthcare REIT For Future Stability
Strong liquidity and successful bond issuance position Medical Properties Trust to cover debt maturities, reducing refinancing risk and improving net margins.Seeking Alpha • Mar 17
Medical Properties: Early Signs Of Stabilization, Maintain Buy
Summary Medical Properties Trust has made significant progress in debt reduction and portfolio stabilization, repaying over $1 billion in debt in the last year. The trust's strategic asset sales and dividend cuts have led to healthier dividend coverage, with a payout ratio of only 44% in 4Q24. Despite a shrinking portfolio and declining funds from operations, MPW's normalized FFO remains stable, suggesting potential for re-rating to book value. Investors should expect high volatility due to the trust's aggressive short interest and potential for further impairments affecting book value. Read the full article on Seeking AlphaSeeking Alpha • Mar 10
Medical Properties Trust: Don't Be Fooled By The Market
Summary Medical Properties Trust investors are fighting against the market, and appear to have vindicated their conviction lately. Management has addressed near-term liquidity issues, but high interest rates could return to haunt investors. MPW's valuation has overcome the pessimistic lows, but don't be too quick to judge that the rally can still carry on. Structural constraints could still hamper its bullish thesis, while fending off policy ambiguities in Trump's healthcare agenda. I argue why the mean reversion trade that underpinned its recent recovery may start to falter. Read the full article on Seeking AlphaSeeking Alpha • Mar 04
Medical Properties: The Rally Can Continue
Summary Medical Properties' Q4 earnings exceeded expectations, boosting shares; the REIT's asset sales enhanced liquidity and supported the $0.08 per-share dividend. I previously recommended Medical Properties as a strong buy due to its asset divestment program, which aids in reducing long-term debt. Despite a 17% share price increase after earnings, Medical Properties has upside potential based off of its historical book valuation. Risks include tenant payment issues and declining NFFO from asset sales, but the dividend remains secure with a 2.25X coverage ratio. Read the full article on Seeking AlphaSeeking Alpha • Feb 24
Medical Properties Trust: A Turnaround Story I'm Not Buying Ahead Of Earnings
Summary Medical Properties Trust (MPW) faces significant risks, including a large debt position and a premium share price compared to its intrinsic value. MPW's portfolio has deteriorated, with key tenant Prospect Medical Group filing for Chapter 11, impacting rent payments and asset values. Asset sales in 2024 aimed to reduce long-term debt, but declining operating income and high interest expenses jeopardize future dividends. Despite a diversified portfolio, MPW's financial health is weak, leading to a sell rating due to high debt levels and uncertain recovery. Read the full article on Seeking AlphaSeeking Alpha • Feb 11
Medical Properties Trust: 45% Short Interest Calls For Caution
Summary Medical Properties Trust bulls have good reason to love the stock: Low P/FFO, high yield, and also a potential turnaround. I also see an equally large downside due to high short interest, uncertain cash flow, and potential dividend sustainability issues. Due to debt levels, valuation should be examined by EV metrics too and is not as cheap as it seems. Read the full article on Seeking AlphaSeeking Alpha • Feb 02
Medical Properties Trust: The Market Finally Seems To Be Catching On
Summary Medical Properties Trust faces challenges with Prospect's Chapter 11 bankruptcy, but benefits from Prospect's focus on California, where most leased assets are located. Private equity firms pose systemic risks to the healthcare sector, with bipartisan legislative efforts underway to address these issues. MPW is securing up to $2.5 billion in secured financing to pay off unsecured debt, lowering interest expenses and lifting dividend restrictions. Moody's upgrade followed immediately. Despite risks, I maintain a Buy rating with a 90% upward potential, targeting +/- $9 a share by Q4, 2026. Read the full article on Seeking AlphaSeeking Alpha • Jan 23
Medical Properties Trust: Issues In Operating Portfolio And Debt Position May Be Priced In
Summary Prospect's bankruptcy is not a negligible impact, as it can lead to a 10% loss in revenues for MPW. Rent coverage analysis gives reasons for caution with other tenants in MPW's portfolio. Declining revenues in the broader tail of operators shows MPW's issues to be broad-based across the portfolio. A large, fixed-rates debt burden is an overhang. And MPW is relying on higher cost funding in order to raise the money needed for debt principal payments. P/B valuations are rather undemanding near multi-decadal lows. Relative technicals indicate a balance of power between the bears and the bulls. Healthcare sector defaults are expected to still be higher than historical norms in 2025 due to high labor costs and cash flow headwinds from certain policies. Read the full article on Seeking AlphaSeeking Alpha • Jan 14
Pride Comes Before The Fall: A Lesson In Intellectual Humility With Medical Properties Trust
Summary My conservative stock-picking approach is rooted in personal financial losses during the Great Recession, emphasizing the value of hard work and intellectual humility. I learned valuable lessons from losing significant equity in real estate, reinforcing the importance of diversification and skepticism towards management. Intellectual humility, as defined by Howard Marks, is crucial for investors; recognizing fallibility and being open to being wrong can prevent significant losses. Moving forward, I will balance between aggressive and defensive strategies, always prepared for economic downturns and avoiding the pitfalls of chasing yield. Read the full article on Seeking AlphaSeeking Alpha • Jan 05
Medical Properties Trust's Bottom Is Likely Here - Brighter Days In H2'25
Summary The bears appear to be winning for now, given that MPW continues to experience elevated short interests as the stock fails to break out of these oversold levels. Even so, the management continues to execute its sale/ re-tenanting process as they reiterate zero exposure to Steward by 2025, with it highlighting its ongoing reversal. Despite challenges from elevated debt and refinancing risks, MPW's discounted valuations and rich forward dividend yields present a unique contrarian buying opportunity. With FY2024 being a trough year and FY2025 likely to bring forth easier YoY comparisons, we may see the stock potentially double over the next few years. We shall further discuss in detail. Read the full article on Seeking AlphaSeeking Alpha • Dec 26
Medical Properties Trust: Punished Beyond What Seems Reasonable, Creating A Deep-Value Opportunity
Summary Medical Properties Trust faces significant challenges with asset reduction, some tenant issues and a high debt level, but diversification efforts are underway. The company's equity has shrunk faster than its debt, partly due to one-time impairments related to Steward Health Care. Revenue is expected to recover beginning in 2025 as new tenants replace Steward and refinancing debt seems manageable. The healthcare industry's recovery and demographic trends support long-term prospects, but labor costs and political risks remain concerns. Shares are trading at very depressed levels, an + 100% upwards potential is very likely. Read the full article on Seeking AlphaSeeking Alpha • Dec 01
Medical Properties Trust: Two Income Opportunities While Investors Wait For Improvements
Summary Medical Properties Trust faces significant financial challenges, but its 2026 bonds offer a near 12% yield with relatively low bankruptcy risk. The company’s earnings have been hit hard, with substantial revenue drops and impairment losses, particularly from its relationship with Steward. Cash flow issues persist, with operating cash flow insufficient to cover capital expenditures and dividends, necessitating asset sales for cash generation and debt reduction. Management's lack of financial guidance adds uncertainty, but income investors can consider near term cash secured put options for potential returns. Read the full article on Seeking AlphaSeeking Alpha • Nov 24
Medical Properties Trust: Oversold And Undervalued Even Against Headwinds
Summary Medical Properties Trust is significantly undervalued, trading at $4.30 per share, 34% below its 52-week high, with a 7.44% dividend yield. MPW has reduced its total debt to $9.2 billion through $2.9 billion in liquidity transactions but faces significant debt maturities in 2025. The REIT's market cap of $2.55 billion is a 53% discount to its shareholders' equity of $5.44 billion, indicating a potential for price recovery. MPW's selloff is driven by inflation concerns and high Treasury yields, but potential Fed rate cuts and asset sales could mitigate debt risks. Read the full article on Seeking AlphaSeeking Alpha • Nov 14
Medical Properties Trust: Investors Should Be Worried About Liquidity Issues Ahead
Summary Medical Properties Trust, Inc. faces severe liquidity issues with significant debt maturities in 2025-2027, raising concerns about the sustainability of its business model. Despite asset sales and secured loans, Medical Properties Trust's poor credit profile and high refinancing costs make new debt issuance financially unfeasible. The company's dividend remains unsustainable, with cash outflows exceeding cash inflows, highlighting ongoing financial distress and liquidity challenges. MPW's refinancing needs and deteriorating leverage metrics suggest a high likelihood of financial distress in the near future. Read the full article on Seeking AlphaSeeking Alpha • Nov 08
Medical Properties Trust: Buy The Dip At A 50% Discount To Book Value
Summary Medical Properties Trust is currently undervalued, trading at a 50% discount to book value, offering a 7% dividend yield, and a forward FFO yield of nearly 20%. The company missed earnings expectations due to tenant issues and accounting changes. Falling interest rates can boost the stock's book value, and the restructuring of Steward assets are expected to lead to more rent generation starting next year. Risks include high debt levels and tenant-related issues, but the company's debt reduction and expected rental income increases provide optimism. The stock has come down recently and is closer to a support level than a resistance level. Read the full article on Seeking AlphaSeeking Alpha • Oct 29
Medical Properties Trust Q3 Preview: Rare Insider Buy Indicates Improving Sentiment
Summary Sentiment may have bottomed and started a turnaround for MPW stock, judging by recent developments. Despite potential impairments, the initial approval of the Steward settlement is a crucial step for MPW to stabilize its finances and recover its operations. A rare insider buy disclosed recently serves as another reflection of the improving sentiment. I anticipate the upcoming Q3 earnings report to provide further support for sentiment turnaround. Read the full article on Seeking AlphaSeeking Alpha • Oct 21
Medical Properties Trust: Why Basket Making Is Important
Summary Medical Properties Trust is a recovery play. The company's issues stem from a high-risk partnership with Steward. One particular area needing work was the evaluation that Steward could always meet cash flow needs. Diversification by investors is crucial. Management must demonstrate improved strategies, and accretive business moves to regain shareholder confidence. Business concentration is okay provided the partner has the finances to justify the level of concentration. Read the full article on Seeking AlphaSeeking Alpha • Oct 12
My Biggest Loser List (Part 1): Medical Properties Trust (Rating Downgrade)
Summary Reflecting on past investment mistakes, I emphasize the importance of humility and continuous learning in becoming a more intelligent investor. Medical Properties Trust faces significant challenges, primarily due to its over-reliance on its largest tenant, Steward, which led to financial instability. Despite management's optimistic communication, MPW's exposure to Steward resulted in unpaid rent, asset sales, and dividend cuts, leading to a Sell rating. While MPW's stock is undervalued, I lack confidence in the management team and recommend avoiding the stock until further improvements are evident. Read the full article on Seeking AlphaSeeking Alpha • Sep 27
Medical Properties Trust Bulls Vs. 40%+ Short Interests
Summary Sentiment surrounding Medical Properties Trust, Inc. has turned very bullish after the Steward settlement was announced. However, the settlement is only a necessary step for the company's future profitability. It does not mean profitability itself or guarantee profitability. Significant challenges remain for MPW after the settlement to be sustainably profitable, ranging from debt to cash flow issues. The low P/AFFO ratio that the bulls like is also misleading. Valuation is not cheap at all when its heavy debt is factored in. Read the full article on Seeking AlphaSeeking Alpha • Sep 20
Medical Properties Trust: The Path To Gains Is Clearer Than Ever
Summary Medical Properties Trust stock is trading at a significant discount to its book value, even after adjusting for expected impairments, suggesting around 50% upside potential. The recent settlement with Steward Health has resolved major issues, allowing MPW to regain control of 23 hospitals and secure new tenants. Book value can increase over time as MPW pays less in dividends, remains profitable on a normalized FFO basis, and benefits from the Federal Reserve's rate cuts. Risks include a large debt load, concentration risk, and a downtrending chart, but the long-term potential justifies a Buy rating. Read the full article on Seeking AlphaSeeking Alpha • Sep 12
Medical Properties Trust Soars On Positive Steward News
Summary Medical Properties Trust, Inc. surged 16% after a positive deal with bankrupt tenant Steward Health Care, showcasing the underlying value of MPW's assets. The deal allows the company to re-tenant 23 hospitals, with 15 already re-tenanted, indicating strong demand for MPW's properties. Medical Properties Trust's shares trade at around 50% of book value, suggesting substantial upside potential despite high debt levels and recent dividend cuts. A potential short squeeze could further boost MPW's share price, providing additional returns for current investors. Read the full article on Seeking AlphaSeeking Alpha • Sep 06
Upgrading Medical Properties Trust On Possible Bullish Catalyst
Summary I'm upgrading MPW stock to a "Buy" today due to potential bullish catalysts, high short interest (39%), and stock price consolidation indicating possible significant upward movement. Q2 2024 results showed mixed performance: GAAP net loss of -$0.54/share, normalized FFO of $0.23/share, and revenue beat expectations by over 5%. A potential recovery of some past write-downs could positively impact financials in the second half of 2024, in my view. Based on a combination of factors, I believe the worst is behind MPW for now - an upcoming bullish catalyst should stimulate a reversal in the medium term. Read the full article on Seeking AlphaSeeking Alpha • Aug 27
Medical Properties Trust: Weak Fundamentals And Bearish Technicals Vs. Low Valuations
Summary My analysis was correct in my last update on Medical Properties Trust, which warned of asset quality risks before the blowup in the stock. But the 'Neutral/Hold' rating was wrong. Impairments in MPW have become too regular of a phenomenon. The company is bleeding cash with negative FFOs and limited cash reserves. Leverage levels are high and unlikely to benefit much from rate cuts due to a high and increased fixed interest rate proportion of total debt. There are signs of operational weakness in the broader tenants portfolio, as evidenced by declining revenues. Given this and bearish technicals, I don't think the low valuations are enough to offset these fundamental headwinds. Read the full article on Seeking AlphaSeeking Alpha • Aug 21
Medical Properties Trust: Cash Flow Concerns Persist
Summary Medical Properties Trust is facing financial struggles due to poor operating performance and high leverage. The company saw a significant decline in total revenues and cash flow, leading to another cut in its dividend. Medical Properties Trust continues to write down investments, eroding shareholder value and facing significant debt maturing in the coming years. Read the full article on Seeking AlphaSeeking Alpha • Aug 14
Medical Properties Trust Is A Steal At This Price (Upgrade)
Summary Medical Properties Trust, Inc. stock has defied bearish investors recently, outperforming the market since my last update. Medical Properties Trust's downgraded dividend payout didn't scare investors off. Management's ability to pay down debt and raise liquidity has justified its optimism about the quality of its asset base. I will explain why. Medical Properties Trust seems to have bottomed out in early 2024, bolstering its recovery thesis. I argue that it is timely for me to turn more bullish on Medical Properties Trust stock. Read on to find out why. Read the full article on Seeking AlphaSeeking Alpha • Aug 06
Medical Properties Trust: Results Incoming
Summary Medical Properties Trust (MPW) likely to experience significant volatility due to upcoming financial results and recent asset sales. Analysts expect revenue and normalized FFO to decline year over year, and other profitability metrics may follow suit. Concerns over bankruptcy of largest tenant, Steward Health Care System, could impact MPW's financial performance, but overall upside potential remains significant. Read the full article on Seeking AlphaSeeking Alpha • Jul 19
Medical Properties Trust: The Endgame Unfolds
Summary Our analysis has been critical of Medical Properties Trust's tenants, particularly Steward Health, which filed for Chapter 11 bankruptcy in May. We developed Cash EBITDA to assess MPW's financial health, revealing a significant decline from $1253M in Q4 2021 to $743.41M now, highlighting the company's financial challenges. Our assessment indicates that asset overvaluation concerns make MPW’s NAV a potentially unreliable measure of market value, underscoring investor misconceptions. We review MPW’s recent refinancing actions and explain why we believe the company, despite recent actions, will still face significant liquidity challenges beginning in 2025. Our valuation models indicate MPW's fair value significantly below its current share price, with equity potentially worthless at higher cap rates, leading us to downgrade MPW to a Strong Sell. Read the full article on Seeking AlphaSeeking Alpha • Jul 03
Medical Properties Trust: Why I Think It Is Worth Having A Pop
Summary Medical Properties Trust, Inc. has faced recent challenges, including an accounting net loss in Q1 and concentration risk from Steward Health Care. Despite its setbacks, MPW's portfolio shows positive rent coverage ratios and a solid interest coverage ratio, indicating resilience in its broader portfolio. MPW's debt metrics seem sound, with a leverage ratio of 54.2% and a long-term debt maturity profile. MPW REIT valuation metrics and dividend yield convey a solid return outlook. Although risks such as Steward Health Care's overhang shouldn't be neglected, we think MPW REIT presents a "buy the dip opportunity." Read the full article on Seeking AlphaSeeking Alpha • Jun 26
Medical Properties Trust: The Market Paints A Bright Future - Ignore
Summary Based on the totality of all factors, I think my downgrade in March 2024 was a great decision. Medical Properties Trust keeps reporting a significant financial deterioration amid a rising debt-to-equity ratio. I see a slow reaction from Wall Street analysts - it heightens the risks of future earnings misses. With a cheap valuation and short interest of 34.35%, I'd definitely not short MPW at the moment. If you're buying MPW stock for the expected dividend, it's probably not a good idea. Despite the potential for turnaround post-restructuring, lack of confidence in management and dividend risks lead to a "Hold" rating. Read the full article on Seeking AlphaSeeking Alpha • Jun 16
Medical Properties Trust's Turnaround Is Here - Initiate Cautious Buy
Summary Steward's bankruptcy is finally here, triggering improved clarity into Medical Properties Trust, Inc.'s ongoing tenant troubles and balance sheet health. The long-awaited dividend announcement also implies the management's focus on shareholder returns, with 2024 likely to bring forth higher liquidity at over $2B. Medical Properties Trust's portfolio diversification and rental collection from other tenants show promise for future performance as well, further aided by its relatively robust interest coverage. Combined with the sustained bullish support observed in its stock prices, we are cautiously upgrading the Medical Properties Trust stock as a Buy. It goes without saying that the stock will remain volatile ahead, attributed to its high short interest, upcoming debt maturity, potential capital raises/debt refinancing, and uncertain Fed pivot. Read the full article on Seeking AlphaSeeking Alpha • Jun 10
Medical Properties Trust: Steward Bankruptcy Exposes Shorts To Squeeze, 11.2% Dividend Yield
Summary Medical Properties Trust is the most shorted US REIT with 36.7% of its outstanding shares currently being sold short. The REIT is paying out an annualized $0.60 per share dividend for an 11.2% yield. This is 160% covered by normalized FFO. A replacement of Steward Health Care System with better-qualified operators in MPW-owned hospitals will drive a material reduction in the risk profile of the REIT. Read the full article on Seeking AlphaSeeking Alpha • Jun 02
Medical Properties Trust: Renewed Risks To The Dividend
Summary Medical Properties Trust faces challenges with increased interest rates and tenant troubles. The bankruptcy of its largest tenant, Steward Health, has had a significant impact on the company's financials. The cash flow statement raises additional concerns as the company had to finance 100% of its dividend payment in the first quarter. Read the full article on Seeking AlphaSeeking Alpha • May 25
Medical Properties Trust Stock: Mr. Market Is Underestimating This REIT
Summary Medical Properties Trust faces difficulties due to high debt and tenant issues, resulting in a significant drop in share price in recent years. However, management is making moves to create shareholder value even after the bankruptcy of its largest tenant. Despite challenges, MPW stock is undervalued, and the company offers significant upside potential for investors. Read the full article on Seeking AlphaSeeking Alpha • May 12
Medical Properties: Don't Worry About The Steward Bankruptcy
Summary Medical Properties reported solid Q1 results despite tenant bankruptcy. Impairment charges related to Steward bankruptcy hurt the REIT's results, but MPW still managed to cover its dividend with NFFO. NFFO-based dividend coverage of 1.6X in Q1, attractive valuation with high safety margin supports a strong buy rating. Read the full article on Seeking AlphaSeeking Alpha • May 05
Medical Properties Trust: Don't Celebrate Too Early
Summary Medical Properties Trust stock saw a significant recovery in April, stunning the short sellers. Several positive catalysts drove the recovery, providing some respite for MPW stock investors. I discuss why these short-term solutions aren't enough to resolve the structural overhang over MPW stock. Notwithstanding the recent outperformance, MPW investors must be judicious about trying to chase further upside. I explain why watching the drama unfolding from the sidelines is wise. Read the full article on Seeking AlphaSeeking Alpha • Apr 25
Very Good News For Medical Properties Trust
Summary Medical Properties Trust is one of the most controversial REITs. It is very speculative and has suffered significant losses lately. Some recent good news is giving us hope. Read the full article on Seeking AlphaSeeking Alpha • Apr 18
Medical Properties Trust: A Key Level Is Now In Sight (Technical Analysis)
Summary Medical Properties Trust sold over $1 billion worth of hospitals, triggering a 19% increase in stock price. The trust's ability to sell hospitals and raise liquidity target improves risk/reward relationship. The stock is approaching a key support level at $5, which could lead to a breakout in 2024. Read the full article on Seeking AlphaSeeking Alpha • Apr 11
Medical Properties Trust: No High Rewards Without High Risks (Rating Upgrade)
Summary Medical Properties Trust has struggled with collecting receivables from its largest tenant and recorded a significant impairment charge in Q4 2023. Despite challenges, MPW has a solid base of healthcare facilities, which are likely to be in high demand in the growing U.S. healthcare industry worth hundreds of billions of dollars. Medical Properties stock's current valuation ratios suggest the company is not far from going bankrupt, but the balance sheet remains solid, and the debt maturity schedule looks comfortable even under current headwinds. Read the full article on Seeking AlphaSeeking Alpha • Apr 04
Medical Properties Trust Q4: Wouldn't Touch This REIT With A 10-Foot Pole
Summary Medical Properties Trust has faced ongoing issues with tenant problems and declining financials. Revenue declined from $1.5 billion to $871.8 million. The company's dividend is at high risk of being cut or eliminated due to liquidity issues and a high payout ratio. FFO declined year-over-year by 69%. MPW's leverage level has increased, indicating potential challenges in the future. Overall, I rate this REIT a strong sell. Despite their efforts to achieve $2 billion in 2024 to satisfy upcoming debt, management's vagueness on the company's future growth prospects concerns me and is a reason investors should avoid. Read the full article on Seeking AlphaShareholder Returns
| MPT | US Health Care REITs | US Market | |
|---|---|---|---|
| 7D | -1.4% | 1.9% | -2.1% |
| 1Y | -4.4% | 29.6% | 18.8% |
Return vs Industry: MPT underperformed the US Health Care REITs industry which returned 29.6% over the past year.
Return vs Market: MPT underperformed the US Market which returned 18.8% over the past year.
Price Volatility
| MPT volatility | |
|---|---|
| MPT Average Weekly Movement | 5.1% |
| Health Care REITs Industry Average Movement | 4.0% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.3% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: MPT has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: MPT's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | 121 | Ed Aldag | www.medicalpropertiestrust.com |
Medical Properties Trust, Inc. is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception, the Company has grown to become one of the world’s largest owners of hospital real estate with 378 facilities and approximately 38,000 licensed beds in nine countries and across three continents as of March 31, 2026. MPT’s financing model facilitates acquisitions and recapitalizations and allows operators of hospitals to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations.
Medical Properties Trust, Inc. Fundamentals Summary
| MPT fundamental statistics | |
|---|---|
| Market cap | US$2.44b |
| Earnings (TTM) | -US$31.60m |
| Revenue (TTM) | US$1.10b |
2.2x
P/S Ratio-77.9x
P/E RatioIs MPT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MPT income statement (TTM) | |
|---|---|
| Revenue | US$1.10b |
| Cost of Revenue | US$44.81m |
| Gross Profit | US$1.06b |
| Other Expenses | US$1.09b |
| Earnings | -US$31.60m |
Last Reported Earnings
Jun 30, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.053 |
| Gross Margin | 95.94% |
| Net Profit Margin | -2.86% |
| Debt/Equity Ratio | 215.7% |
How did MPT perform over the long term?
See historical performance and comparisonDividends
8.7%
Current Dividend Yield50%
Payout RatioDoes MPT pay a reliable dividends?
See MPT dividend history and benchmarks| Medical Properties Trust dividend dates | |
|---|---|
| Ex Dividend Date | Sep 10 2026 |
| Dividend Pay Date | Oct 08 2026 |
| Days until Ex dividend | 19 days |
| Days until Dividend pay date | 47 days |
Does MPT pay a reliable dividends?
See MPT dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/08/21 22:03 |
| End of Day Share Price | 2026/08/21 00:00 |
| Earnings | 2026/06/30 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Medical Properties Trust, Inc. is covered by 24 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Andrew Babin | Baird |
| Steven Valiquette | Barclays |
| Connor Siversky | Berenberg |